Reza Yarani

1.6k total citations
72 papers, 1.2k citations indexed

About

Reza Yarani is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Reza Yarani has authored 72 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 20 papers in Cancer Research and 13 papers in Surgery. Recurrent topics in Reza Yarani's work include Extracellular vesicles in disease (15 papers), Mesenchymal stem cell research (13 papers) and MicroRNA in disease regulation (8 papers). Reza Yarani is often cited by papers focused on Extracellular vesicles in disease (15 papers), Mesenchymal stem cell research (13 papers) and MicroRNA in disease regulation (8 papers). Reza Yarani collaborates with scholars based in Denmark, Iran and United States. Reza Yarani's co-authors include Flemming Pociot, Kamran Mansouri, Simranjeet Kaur, Aashiq H. Mirza, Hassan Rasouli, Jelena Popović‐Djordjević, Sadat Dokaneheifard, Zohreh Hoseinkhani, Avnesh S. Thakor and Sara Kiani and has published in prestigious journals such as Nucleic Acids Research, Nano Letters and Scientific Reports.

In The Last Decade

Reza Yarani

66 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Reza Yarani Denmark 20 603 352 133 99 97 72 1.2k
Aysa Rezabakhsh Iran 24 793 1.3× 278 0.8× 142 1.1× 105 1.1× 137 1.4× 83 1.6k
Dan Yi China 21 666 1.1× 196 0.6× 91 0.7× 47 0.5× 84 0.9× 71 1.4k
Khadijeh Jamialahmadi Iran 17 640 1.1× 156 0.4× 78 0.6× 87 0.9× 95 1.0× 61 1.2k
Bai‐Cheng He China 29 1.3k 2.1× 323 0.9× 124 0.9× 115 1.2× 137 1.4× 86 2.0k
Fengxia Liu China 23 886 1.5× 493 1.4× 75 0.6× 63 0.6× 97 1.0× 99 1.6k
Zhipeng Su China 19 622 1.0× 250 0.7× 117 0.9× 136 1.4× 206 2.1× 76 1.3k
Jia Yang China 17 507 0.8× 244 0.7× 125 0.9× 97 1.0× 182 1.9× 40 965
Jingjing Wang China 22 962 1.6× 241 0.7× 143 1.1× 46 0.5× 126 1.3× 102 1.8k

Countries citing papers authored by Reza Yarani

Since Specialization
Citations

This map shows the geographic impact of Reza Yarani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reza Yarani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reza Yarani more than expected).

Fields of papers citing papers by Reza Yarani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reza Yarani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reza Yarani. The network helps show where Reza Yarani may publish in the future.

Co-authorship network of co-authors of Reza Yarani

This figure shows the co-authorship network connecting the top 25 collaborators of Reza Yarani. A scholar is included among the top collaborators of Reza Yarani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reza Yarani. Reza Yarani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shojaeian, Ali, et al.. (2025). Antimicrobial Peptides Against Arboviruses: Mechanisms, Challenges, and Future Directions. Probiotics and Antimicrobial Proteins. 17(4). 2058–2085. 2 indexed citations
2.
Bakhtiari, Mitra, et al.. (2025). The supportive role of stem cells-derived exosomes in the embryo implantation process by regulating oxidative stress. Biomedicine & Pharmacotherapy. 188. 118171–118171. 2 indexed citations
3.
Yarani, Reza, et al.. (2024). L-lysine Increases the Anticancer Effect of Doxorubicin in Breast Cancer by Inducing ROS-dependent Autophagy. Current Cancer Drug Targets. 25(3). 257–269.
5.
Zamanian, Mohammad Hossein, Amir Hossein Norooznezhad, Feizollah Mansouri, et al.. (2024). Human placental mesenchymal stromal cell‐derived small extracellular vesicles as a treatment for severe COVID‐19: A double‐blind randomized controlled clinical trial. Journal of Extracellular Vesicles. 13(7). e12492–e12492. 20 indexed citations
6.
Nejsum, Peter, et al.. (2024). Unleashing the potential of extracellular vesicles for ulcerative colitis and Crohn's disease therapy. Bioactive Materials. 45. 41–57. 4 indexed citations
7.
Yarani, Reza, Nikolaj Travica, Zahra Yousefi, et al.. (2023). Anti-diabetic Properties of Melissa officinalis and Saffron: Recent Advances and Discoveries. Gazi Medical Journal. 34(4).
8.
Levitte, Steven, Reza Yarani, John Gubatan, et al.. (2023). Case Series of Precision Delivery of Methylprednisolone in Pediatric Inflammatory Bowel Disease: Feasibility, Clinical Outcomes, and Identification of a Vasculitic Transcriptional Program. Journal of Clinical Medicine. 12(6). 2386–2386. 7 indexed citations
9.
Yarani, Reza, Zahra Yousefi, Seyed Kazem Shakouri, et al.. (2022). Phytochemical and pharmacological anti-diabetic properties of bilberries (Vaccinium myrtillus), recommendations for future studies. Primary care diabetes. 16(1). 27–33. 19 indexed citations
10.
Kaur, Simranjeet, Aashiq H. Mirza, Tina Fløyel, et al.. (2022). Pro-Inflammatory Cytokines Promote the Transcription of Circular RNAs in Human Pancreatic β Cells. Non-Coding RNA. 8(5). 69–69. 2 indexed citations
11.
Yarani, Reza, et al.. (2022). Targeting endothelial cell metabolism in cancerous microenvironment: a new approach for anti-angiogenic therapy. Drug Metabolism Reviews. 54(4). 386–400. 10 indexed citations
12.
Swaminathan, G. Jawahar, Fernando Jose Garcia-Marques, Shobha Regmi, et al.. (2022). Integrated transcriptome-proteome analyses of human stem cells reveal source-dependent differences in their regenerative signature. Stem Cell Reports. 18(1). 190–204. 19 indexed citations
13.
Hoseinkhani, Zohreh, et al.. (2021). Altering the characterization of nanofibers by changing the electrospinning parameters and their application in tissue engineering, drug delivery, and gene delivery systems. Polymers for Advanced Technologies. 32(5). 1924–1950. 29 indexed citations
14.
Mohammadi, Pantea, et al.. (2021). Carbohydrate and lipid metabolism in multiple sclerosis: Clinical implications for etiology, pathogenesis, diagnosis, prognosis, and therapy. Archives of Biochemistry and Biophysics. 712. 109030–109030. 13 indexed citations
15.
Mansouri, Kamran, et al.. (2021). Diabetes complications and extracellular vesicle therapy. Reviews in Endocrine and Metabolic Disorders. 23(3). 357–385. 16 indexed citations
16.
Araj‐Khodaei, Mostafa, Ahmad Ali Noorbala, Reza Yarani, et al.. (2020). A double-blind, randomized pilot study for comparison of Melissa officinalis L. and Lavandula angustifolia Mill. with Fluoxetine for the treatment of depression. BMC Complementary Medicine and Therapies. 20(1). 207–207. 47 indexed citations
17.
Azadbakht, Mehri, et al.. (2018). L-arginine/5-fluorouracil combination treatment approaches cells selectively: Rescuing endothelial cells while killing MDA-MB-468 breast cancer cells. Food and Chemical Toxicology. 123. 399–411. 18 indexed citations
18.
Ahmadi, Mona, et al.. (2016). Multiple sclerosis influences on the augmentation of serum Klotho concentration. Journal of the Neurological Sciences. 362. 69–72. 12 indexed citations
20.
Rahimi, Zohreh, Zohreh Rahimi, Asad Vaisi‐Raygani, et al.. (2011). Association Between Cholesteryl Ester Transfer Protein TaqIB Variants and Risk of Coronary Artery Disease and Diabetes Mellitus in the Population of Western Iran. Genetic Testing and Molecular Biomarkers. 15(11). 813–819. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026